Subscribe To
Amazon just struck a new ai partnership with anthropic for its in-house chips
Amazon is investing in AI start-up Anthropic and in exchang...
November 2, 2023, 9:30 am
Gbpusd tests key descending trendline
GBPUSD slightly higher today as market digests Fed meeting It tests again the July 14 aggressive descen...
November 2, 2023, 9:29 am
New btc price breakouts see bitcoin traders confirm targets up to $48k
Now returning to test the mettle of $35,000 as support, Bitcoin is on the radar of market participants,...
November 2, 2023, 9:29 am
Gbp/usd forecast: pound sterling needs a hawkish boe to clear 1.2200
GBP/USD gathered bullish momentum and registered gains on Wednesday after dropping below 1.2100 earlier...
November 2, 2023, 9:29 am
Wti oil futures succumb to bearish pressures
WTI futures decline after rejection at 50-day SMA Found their feet around the 80.00 handle, forming pot...
November 2, 2023, 9:28 am
Tnr gold updates on new investment into mcewan mining's los azules project
TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) has shared a recent update on the Los Azules copper, gold, and silver project in Argentina, which is bei...
November 2, 2023, 9:26 am
Japan pm kishida says will push firms to achieve higher wage hikes next year
Wants to ensure that growth in household income exceeds pace of inflationI reckon it's a consistent theme now across the board that we are goi...
November 2, 2023, 9:26 am
Novavax to host conference call to discuss third quarter 2023 financial results and operational highlights on november 9, 2023
GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing...
November 2, 2023, 9:25 am
Talon metals signs agreement with us doe for $114.8m in bipartisan infrastructure law funding
Talon Metals Corp. (TSX:TLO, OTC:TLOFF) told investors it has signed a definitive agreement with the US Department of Energy (DOE) setti...
November 2, 2023, 9:24 am
Federal reserve maintains the status quo: overview for november 02, 2023
After the November meeting of the Federal Reserve, the EUR/USD pair maintained its neutral position. Th...
November 2, 2023, 9:24 am
Pausing on palantir: why pltr stock is not worth the gamble today
Tech firm Palantir Technologies (NASDAQ: PLTR ) had a turbulent few years. On a year-to-date basis, PLTR stock has surged more than 130%....
November 2, 2023, 9:23 am
The aud surges to three-week highs: overview for november 02, 2023
The AUD/USD pair strengthens its position while the US dollar remains neutral. The post The AUD Surges ...
November 2, 2023, 9:21 am
Sedg stock plummets as multiple analysts downgrade solaredge
Solaredge Technologies (NASDAQ: SEDG ) stock is falling on Thursday after the company's shares were hit...
November 2, 2023, 9:21 am
Sainsbury's persistence on value now vital - analysts
Strong half-year trading for J Sainsbury PLC (LSE:SBRY) ...
November 2, 2023, 9:21 am
Venezuela's october oil exports fall 19% despite u.s. easing sanctions
Venezuela's oil exports declined in October to less than 700,000 barrels per day (bpd) amid operational hiccups at the country's main production regio...
November 2, 2023, 9:20 am
Is alphabet a buy?
Alphabet's revenue and earnings beat expectations, but cloud revenue was a disappointment. The business...
November 2, 2023, 9:20 am
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developi...
November 2, 2023, 9:17 am
Paypal gets a lift. why the stock could be too cheap to fail.
An earnings beat and new management are putting turnarou...
November 2, 2023, 9:16 am
Gold price forecast – gold markets recover slightly on thursday
Gold markets rallied just a bit during the trading sessi...
November 2, 2023, 9:15 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLIngAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a c...
November 2, 2023, 9:15 am